Applications

1330 – Transcatheter closure of a patent ductus arteriosus

Find out about the service or technology in this application and the medical condition it addresses. You can also view the application documents, the deadlines for providing consultation input and the outcome of the application when the MSAC process is complete.

  • Status Complete
  • Type New application
  • Pre-PASC consultation -
  • Pre-MSAC consultation -
  • Outcome Supported

Application details

Reason for application

New MBS item.

Service or technology in this application

Transcatheter closure of a patent ductus arterious is now standard management for this lesion. The procedure is usually performed under general anaesthesia and access is obtained utilising both the femoral artery and femoral vein. Angiographic images are obtained of the patent ductus arteriosus prior to closure. The patent ductus is then crossed with a catheter and an occlusion device is deployed which will result in complete occulusin of the patent ductus.

Type: Therapeutic

Medical condition this application addresses

The patent ductus arteriosus is a vessel which communicates between the aorta and main pulmonary artery. It is a vessel which is present in foetal and should close following delivery. In those patients who do have a persisting patent ductus they can develop symptoms of cardiac failure and in the adult population there is a risk of endocarditis and late ventricular failure. The mechanism of this is increased blood flow to the lungs and left ventricle.

Application documents

Meetings to consider this application

  • PASC meeting: 13 – 14 December 2012
  • ESC meeting: 13 – 14 June 2013
  • MSAC meeting: 
    • 1 August 2013
    • 23 November 2017